CIA
ABBV icon

Compass Ion Advisors’s AbbVie ABBV Stock Holding History

Compass Ion Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.19M Sell
8,697
-371
-4% -$79.8K 0.19% 64
2026
Q1 		$1.97M Sell
9,068
-267
-3% -$59.2K 0.19% 66
2025
Q4 		$2.13M Buy
9,335
+23
+0.2% +$5.24K 0.2% 60
2025
Q3 		$2.16M Sell
9,312
-17
-0.2% -$3.46K 0.21% 56
2025
Q2 		$1.73M Sell
9,329
-10
-0.1% -$1.86K 0.19% 63
2025
Q1 		$1.96M Sell
9,339
-317
-3% -$61.6K 0.23% 54
2024
Q4 		$1.72M Sell
9,656
-139
-1% -$25.6K 0.2% 67
2024
Q3 		$1.93M Sell
9,795
-26
-0.3% -$4.85K 0.24% 60
2024
Q2 		$1.79M Hold
9,821
– – 0.26% 55
2024
Q1 		$1.79M Buy
9,821
+26
+0.3% +$4.48K 0.26% 56
2023
Q4 		$1.52M Buy
9,795
+609
+7% +$88.8K 0.24% 62
2023
Q3 		$1.37M Buy
+9,186
New +$1.35M 0.23% 68

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Compass Ion Advisors's ABBV Position: Q2 2026 in Review

Compass Ion Advisors reduced its AbbVie (ABBV) stake by 4.1% in Q2 2026, selling an estimated $79.8K and leaving 8,697 shares worth $2.19M. The position accounts for 0.19% of the portfolio, ranked #64.

Compass Ion Advisors first reported a position in ABBV in Q3 2023 and has held it in 12 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Compass Ion Advisors held 8,697 shares of AbbVie worth $2.19M as of Q2 2026.
  • Compass Ion Advisors sold 371 AbbVie shares in Q2 2026, an estimated $79.8K.
  • AbbVie made up 0.19% of Compass Ion Advisors's portfolio in Q2 2026, its #64 holding.
  • Compass Ion Advisors first reported a position in AbbVie in Q3 2023 and has held it in 12 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Compass Ion Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.